There are different factors in every country affecting the clinical trials as all the countries have an organization such as FDA that takes the authority for every clinical trial within the country and controls the security of pill, tablet, treatment and everything that goes to the market. But there are some key differences as given below:
1. Regulatory authority:
Countries can have their own cultural ways of administration as some countries have PMDA that stands for pharmaceutical and medical device authority. This organization administers every pill, tablet and treatment before it goes to the market and takes authority for every clinical trial within the country. It works for the same purpose but has some different regulations and principles.
2. Cultural boundaries:
As moving from one place to another, things changes, temperature changes and when we moving to another country, they have their own cultures and regulations. Countries have their own rules to run clinical trials. They can prefer communication through personal interaction over virtual communication and a number of pre-monitoring visits before starting the studies trials at site. There can be communication and accent barriers when running clinical trials across the border in another country.
3. Separate team:
Countries do have their own well experienced team to operate clinical trials within their country because they are well versed of their country’s cultures and protocols to run clinical trials.
These are the factors involved in running clinical trials across the border which should be given proper attention for successful results.